Development
Core Scientific, Inc.
CORZ
$12.19
$0.262.18%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 112.07M | 129.10M | 181.33M | 205.63M | 242.52M |
| Total Other Revenue | 390.33M | 352.62M | 350.06M | 362.82M | 397.80M |
| Total Revenue | 502.40M | 481.72M | 531.39M | 568.45M | 640.31M |
| Cost of Revenue | 378.94M | 444.81M | 536.97M | 598.27M | 631.91M |
| Gross Profit | 123.46M | 36.92M | -5.58M | -29.82M | 8.40M |
| SG&A Expenses | 100.93M | 111.46M | 129.29M | 203.48M | 222.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 513.00K | 346.00K | -3.02M | 135.19M | 187.02M |
| Total Operating Expenses | 487.57M | 564.58M | 675.14M | 961.98M | 1.07B |
| Operating Income | 14.84M | -82.86M | -143.76M | -393.53M | -427.85M |
| Income Before Tax | -245.80M | -506.78M | -889.90M | -1.74B | -2.16B |
| Income Tax Expenses | 683.00K | -21.14M | -10.61M | -59.39M | -17.09M |
| Earnings from Continuing Operations | -246.49 | -485.64 | -879.29 | -1.68K | -2.15K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -246.49M | -485.64M | -879.29M | -1.68B | -2.15B |
| EBIT | 14.84M | -82.86M | -143.76M | -393.53M | -427.85M |
| EBITDA | 110.84M | 50.66M | 30.10M | -190.31M | -202.59M |
| EPS Basic | -0.64 | -1.20 | -2.32 | -4.79 | -6.30 |
| Normalized Basic EPS | -0.12 | -0.16 | -0.31 | -0.82 | -0.92 |
| EPS Diluted | -0.66 | -1.21 | -2.33 | -4.80 | -6.31 |
| Normalized Diluted EPS | -0.12 | -0.16 | -0.31 | -0.82 | -0.92 |
| Average Basic Shares Outstanding | 1.52B | 1.54B | 1.51B | 1.46B | 1.39B |
| Average Diluted Shares Outstanding | 1.52B | 1.54B | 1.51B | 1.46B | 1.39B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |